Mesa Laboratories: Hard To Set The Right Diagnosis (NASDAQ:MLAB)

Group 1 - The article discusses the recent performance of Mesa Laboratories, Inc. (MLAB), highlighting a recovery in its share price from the $70s to nearly $100 in recent weeks, indicating a potential investment opportunity in the life science tools sector [1] - The service "Value in Corporate Events" provides coverage of major corporate events such as earnings reports, M&A, and IPOs, aiming to identify actionable investment ideas [1] - The investing group focuses on finding the best opportunities by analyzing around 10 major events each month, which includes tracking companies through catalytic events [1]